Caris Life Sciences (CAI) Other Non Operating Income (2024 - 2026)
Caris Life Sciences (CAI) recorded quarterly Other Non Operating Income of $49000.0 in Q1 2026, up 102.32% quarter-over-quarter from -$2.1 million in Q4 2025, and up 388.24% on a YoY basis from $10036.1 in Q1 2025.
Caris Life Sciences (CAI) Other Non Operating Income (2024 - 2026) Analysis & Trends
Caris Life Sciences' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $49000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 388.24% year-over-year to $49000.0; the TTM figure through Mar 2026 stood at -$20.5 million (down 13841.5% YoY), while the FY2025 annual figure was -$20.6 million, down 5791.12% from the prior year.
- Other Non Operating Income was $49000.0 for Q1 2026 at Caris Life Sciences, up from -$2.1 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $49000.0 in Q1 2026 to a low of -$18.3 million in Q2 2025.
- Historically, Other Non Operating Income has averaged -$2.6 million across 3 years, with a median of -$57500.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income tumbled 12907.8% in 2025, then surged 388.24% in 2026.
- A 3-year view of Other Non Operating Income shows it stood at -$26000.0 in 2024, then slumped by 8026.92% to -$2.1 million in 2025, then jumped by 102.32% to $49000.0 in 2026.
- The last three Other Non Operating Income figures came in at $49000.0 (Q1 2026), -$2.1 million (Q4 2025), and -$89000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Caris Life Sciences | 5.22 Bn | 4.40 Bn | 171.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,000.00 |
| Dec 31, 2025 | -2.11 Mn |
| Sep 30, 2025 | -89,000.00 |
| Jun 30, 2025 | -18.34 Mn |
| Mar 31, 2025 | -17,000.00 |
| Dec 31, 2024 | -26,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Jun 30, 2024 | -141,000.00 |